Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Biopharmaceutical Contract Manufacturing Market by Type (Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Others), By Application (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Biopharmaceutical Contract Manufacturing Market by Type (Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Others), By Application (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 310110 4200 Medical Care 377 229 Pages 4.8 (31)
                                          

Industry Growth Insights published a new data on “Biopharmaceutical Contract Manufacturing Market”. The research report is titled “Biopharmaceutical Contract Manufacturing Market research by Types (Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Others), By Applications (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others), By Players/Companies Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva, Probiogen, Cytovance Biologics, KBI Biopharma, WuXi Biologics, Abzena”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Biopharmaceutical Contract Manufacturing Market Research Report

By Type

Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Others

By Application

Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others

By Companies

Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva, Probiogen, Cytovance Biologics, KBI Biopharma, WuXi Biologics, Abzena

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

229

Number of Tables & Figures

161

Customization Available

Yes, the report can be customized as per your need.


Global Biopharmaceutical Contract Manufacturing Industry Outlook


Global Biopharmaceutical Contract Manufacturing Market Report Segments:

The global Biopharmaceutical Contract Manufacturing market is segmented on the basis of:

Types

Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Lonza Group
  2. Baxter Biopharma Solutions
  3. Samsung
  4. Fujifilm Diosynth Biotechnologies
  5. Boehringer Ingelheim
  6. Patheon
  7. Rentschler Biotechnologie
  8. Biomeva
  9. Probiogen
  10. Cytovance Biologics
  11. KBI Biopharma
  12. WuXi Biologics
  13. Abzena

Global Biopharmaceutical Contract Manufacturing Market Overview


Highlights of The Biopharmaceutical Contract Manufacturing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Growth Factors
    2. Interferons
    3. Monoclonal Antibodies
    4. Recombinant Hormones
    5. Vaccines
    6. Insulin
    7. Others
  1. By Application:

    1. Autoimmune Diseases
    2. Oncology
    3. Metabolic Diseases
    4. Ophthalmology
    5. Cardiovascular Diseases
    6. Infectious Diseases
    7. Neurology
    8. Respiratory Disorders
    9. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biopharmaceutical Contract Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Biopharmaceutical Contract Manufacturing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Biopharmaceutical contract manufacturing is a process by which pharmaceutical companies contract with third-party manufacturers to produce specific products. This service can be used for both new and existing products, and allows the company to focus on its core business while the manufacturer handles all of the production logistics.

Some of the major companies in the biopharmaceutical contract manufacturing market are Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva, Probiogen, Cytovance Biologics, KBI Biopharma, WuXi Biologics, Abzena.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopharmaceutical Contract Manufacturing Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Biopharmaceutical Contract Manufacturing Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Biopharmaceutical Contract Manufacturing Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Biopharmaceutical Contract Manufacturing Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Biopharmaceutical Contract Manufacturing Market Size & Forecast, 2020-2028       4.5.1 Biopharmaceutical Contract Manufacturing Market Size and Y-o-Y Growth       4.5.2 Biopharmaceutical Contract Manufacturing Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Growth Factors
      5.2.2 Interferons
      5.2.3 Monoclonal Antibodies
      5.2.4 Recombinant Hormones
      5.2.5 Vaccines
      5.2.6 Insulin
      5.2.7 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Autoimmune Diseases
      6.2.2 Oncology
      6.2.3 Metabolic Diseases
      6.2.4 Ophthalmology
      6.2.5 Cardiovascular Diseases
      6.2.6 Infectious Diseases
      6.2.7 Neurology
      6.2.8 Respiratory Disorders
      6.2.9 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Biopharmaceutical Contract Manufacturing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Biopharmaceutical Contract Manufacturing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Growth Factors
      9.6.2 Interferons
      9.6.3 Monoclonal Antibodies
      9.6.4 Recombinant Hormones
      9.6.5 Vaccines
      9.6.6 Insulin
      9.6.7 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Autoimmune Diseases
      9.10.2 Oncology
      9.10.3 Metabolic Diseases
      9.10.4 Ophthalmology
      9.10.5 Cardiovascular Diseases
      9.10.6 Infectious Diseases
      9.10.7 Neurology
      9.10.8 Respiratory Disorders
      9.10.9 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Growth Factors
      10.6.2 Interferons
      10.6.3 Monoclonal Antibodies
      10.6.4 Recombinant Hormones
      10.6.5 Vaccines
      10.6.6 Insulin
      10.6.7 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Autoimmune Diseases
      10.10.2 Oncology
      10.10.3 Metabolic Diseases
      10.10.4 Ophthalmology
      10.10.5 Cardiovascular Diseases
      10.10.6 Infectious Diseases
      10.10.7 Neurology
      10.10.8 Respiratory Disorders
      10.10.9 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Growth Factors
      11.6.2 Interferons
      11.6.3 Monoclonal Antibodies
      11.6.4 Recombinant Hormones
      11.6.5 Vaccines
      11.6.6 Insulin
      11.6.7 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Autoimmune Diseases
      11.10.2 Oncology
      11.10.3 Metabolic Diseases
      11.10.4 Ophthalmology
      11.10.5 Cardiovascular Diseases
      11.10.6 Infectious Diseases
      11.10.7 Neurology
      11.10.8 Respiratory Disorders
      11.10.9 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Growth Factors
      12.6.2 Interferons
      12.6.3 Monoclonal Antibodies
      12.6.4 Recombinant Hormones
      12.6.5 Vaccines
      12.6.6 Insulin
      12.6.7 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Autoimmune Diseases
      12.10.2 Oncology
      12.10.3 Metabolic Diseases
      12.10.4 Ophthalmology
      12.10.5 Cardiovascular Diseases
      12.10.6 Infectious Diseases
      12.10.7 Neurology
      12.10.8 Respiratory Disorders
      12.10.9 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Growth Factors
      13.6.2 Interferons
      13.6.3 Monoclonal Antibodies
      13.6.4 Recombinant Hormones
      13.6.5 Vaccines
      13.6.6 Insulin
      13.6.7 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Autoimmune Diseases
      13.10.2 Oncology
      13.10.3 Metabolic Diseases
      13.10.4 Ophthalmology
      13.10.5 Cardiovascular Diseases
      13.10.6 Infectious Diseases
      13.10.7 Neurology
      13.10.8 Respiratory Disorders
      13.10.9 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Biopharmaceutical Contract Manufacturing Market: Competitive Dashboard
   14.2 Global Biopharmaceutical Contract Manufacturing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Lonza Group
      14.3.2 Baxter Biopharma Solutions
      14.3.3 Samsung
      14.3.4 Fujifilm Diosynth Biotechnologies
      14.3.5 Boehringer Ingelheim
      14.3.6 Patheon
      14.3.7 Rentschler Biotechnologie
      14.3.8 Biomeva
      14.3.9 Probiogen
      14.3.10 Cytovance Biologics
      14.3.11 KBI Biopharma
      14.3.12 WuXi Biologics
      14.3.13 Abzena

Our Trusted Clients

Contact Us